Pfizer asks for US authorisation of Covid vaccine for ages 5-11

Published Thu, Oct 7, 2021 · 09:15 PM

[NEW YORK] US drugmaker Pfizer said on Thursday it has formally requested emergency use authorisation for its Covid-19 vaccine in children age five to 11.

Children have been infected in greater numbers in the latest coronavirus wave driven by the Delta variant, and inoculating young people is seen as key to keeping schools open and helping end the pandemic.

In late September, Pfizer and BioNTech, which co-developed the vaccine, began submitting data to the Food and Drug Administration (FDA) regulators for the highly anticipated authorisation.

Pfizer tweeted early on Thursday that the two companies had "officially submitted our request" to the FDA "for Emergency Use Authorization (EUA) of our #Covid19 vaccine in children 5 to 12".

"We're committed to working with the FDA with the ultimate goal of helping protect children against this serious public health threat," Pfizer said.

Following the announcement White House Covid coordinator Jeff Zients told CNN: "I think we can all agree that getting a safe and effective vaccine for kids five to 11 is a really important next step in our fight against the virus."

GET BT IN YOUR INBOX DAILY

Start and end each day with the latest news stories and analyses delivered straight to your inbox.

VIEW ALL

Children in the 5-11 age group received a two-dose regimen of 10 micrograms in the trial, compared with 30 micrograms for older age groups. The shots were given 21 days apart.

The FDA has previously said that once the formal submission was completed, the agency would complete its review "likely in a matter of weeks rather than months".

The Pfizer-BioNTech vaccine has been granted full FDA approval for those age 16 and up.

AFP

KEYWORDS IN THIS ARTICLE

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to  t.me/BizTimes

International

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

Get the latest coverage and full access to all BT premium content.

SUBSCRIBE NOW

Browse corporate subscription here